Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LENS

Presbia (LENS) Stock Price, News & Analysis

Presbia logo

About Presbia Stock (NASDAQ:LENS)

Advanced Chart

Key Stats

Today's Range
$26.87
$26.95
50-Day Range
$0.07
$0.32
52-Week Range
$0.23
$5.50
Volume
801 shs
Average Volume
122,366 shs
Market Capitalization
$463.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Presbia PLC is a holding company. It engages in the development and marketing of presbyopia-correcting solutions under the trademark of Presbia Flexivue Microlens. It operates through the Restoration of Clear Vision Caused by Presbyopia segment. The company was founded on February 2, 2014 and is headquartered in Dublin, Ireland.

Receive LENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Presbia and its competitors with MarketBeat's FREE daily newsletter.

LENS Stock News Headlines

Contact Lens King Coupons
The “80/20” stock calendar
Imagine having a “trading calendar” with what could be the EXACT dates to buy and sell some of your favorite stocks… I’m talking about popular stocks like Apple, Walmart and even Google! Imagine being able to hone in on the only days of the year that our backtesting has found are historically shown to yield the BIGGEST opportunities... With these unique sheets in your hands, designed to help you decide when to confidently enter AND exit trades... Sounds crazy? The crazy thing is that this ability exists RIGHT NOW.
Real and virtual images
Types of lens
Convex and concave lenses
See More Headlines

LENS Stock Analysis - Frequently Asked Questions

Presbia PLC (NASDAQ:LENS) issued its quarterly earnings results on Friday, August, 12th. The medical instruments supplier reported ($0.32) EPS for the quarter, missing analysts' consensus estimates of ($0.25) by $0.07. The medical instruments supplier earned $0.01 million during the quarter, compared to the consensus estimate of $0.04 million. Presbia had a negative trailing twelve-month return on equity of 414.02% and a negative net margin of 36,604.35%.

Presbia (LENS) raised $50 million in an initial public offering (IPO) on Thursday, January 29th 2015. The company issued 4,200,000 shares at a price of $11.00-$13.00 per share. Jefferies acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Presbia investors own include Ritter Pharmaceuticals (RTTR), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Bellatrix Exploration (BXE), Second Sight Medical Products (EYES), Lilis Energy (LLEX) and Marinus Pharmaceuticals (MRNS).

Company Calendar

Last Earnings
8/12/2016
Today
5/25/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:LENS
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,410,000.00
Net Margins
-36,604.35%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20,000.00
Price / Sales
23,180.29
Price / Cash Flow
N/A
Book Value
$0.09 per share
Price / Book
298.97

Miscellaneous

Free Float
N/A
Market Cap
$463.61 million
Optionable
Not Optionable
Beta
2.57
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:LENS) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners